Adrian Senderowicz

CIK: 0001616230

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

AVXL

ANAVEX LIFE SCIENCES CORP.

Director

PBYI

PUMA BIOTECHNOLOGY, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

PBYI
PUMA BIOTECHNOLOGY, INC.
Jun 12, 2026
Sale(S)
Direct
27K shares at avg. $7.20$194K
PBYI
PUMA BIOTECHNOLOGY, INC.
Jun 11, 2026
Award(A)
Direct
27K shares-
PBYI
PUMA BIOTECHNOLOGY, INC.
Jun 13, 2025
Sale(S)
Direct
27K shares at avg. $3.40$92K
PBYI
PUMA BIOTECHNOLOGY, INC.
Jun 11, 2025
Award(A)
Direct
27K shares-

		Type	Shares	Price		Ownership
Jun 12, 2026	PBYI PUMA BIOTECHNOLOGY, INC.	Sale(S)	27,000	$7.20	$194,311	Direct
Jun 11, 2026	PBYI PUMA BIOTECHNOLOGY, INC.	Award(A)	27,000	-	$0	Direct
Jun 13, 2025	PBYI PUMA BIOTECHNOLOGY, INC.	Sale(S)	27,000	$3.40	$91,800	Direct
Jun 11, 2025	PBYI PUMA BIOTECHNOLOGY, INC.	Award(A)	27,000	-	-	Direct

1-4 of 4 transactions

About Senderowicz Adrian

Senderowicz Adrian (SEC CIK 0001616230) files insider reports with the SEC as Director of ANAVEX LIFE SCIENCES CORP. (AVXL) and Director of PUMA BIOTECHNOLOGY, INC. (PBYI).

Signal8 holds 4 ownership filings by Senderowicz Adrian (1 Form 3, 3 Form 4), filed between Jun 13, 2025 and Oct 5, 2026. Those filings report 4 transactions, from Jun 11, 2025 to Jun 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Senderowicz Adrian's filings is in NEW YORK, NY.

Recent filings by Senderowicz Adrian

Jun 12, 2026: Open-market sale of PBYI shares (Form 4, code S).
Jun 11, 2026: Grant or award of PBYI shares (Form 4, code A).
Jun 13, 2025: Open-market sale of PBYI shares (Form 4, code S).
Jun 11, 2025: Grant or award of PBYI shares (Form 4, code A).

Other insiders filing for ANAVEX LIFE SCIENCES CORP. (AVXL)

Patel Gautam, Director
Boenisch Sandra, PFO & Treasurer
Kellmeyer Terrie, Interim CEO
Paeger Axel, Director
MISSLING CHRISTOPHER U, President and CEO
Thomas Steffen, Director

How to read Form 4 transaction codes